As my recent post documented, SUD treatment is both effective for patients and has large, positive spillovers to society. So why is it underfunded and underprovided? In my latest AcademyHealth post, I offer some answers.
Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist and tweets at @afrakt. His day job is Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs. He is also a Professor with the Department of Health Law, Policy and Management at the Boston University’s School of Public Health, a Senior Research Scientist with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and Editor-in-Chief of the journal Health Services Research.